Article

You have full text access to this OnlineOpen article

Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices

  1. George E. Davis†,*,
  2. Kayla J. Bayless,
  3. Anil Mavila

Article first published online: 14 OCT 2002

DOI: 10.1002/ar.10159

Issue

The Anatomical Record

The Anatomical Record

Special Issue: Astrobiology

Volume 268, Issue 3, pages 252–275, 1 November 2002

Additional Information

How to Cite

Davis, G. E., Bayless, K. J. and Mavila, A. (2002), Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices. Anat. Rec., 268: 252–275. doi: 10.1002/ar.10159

Author Information

  1. Department of Pathology, Texas A&M University System Health Science Center, College Station, Texas

  1. †

    Fax: (979) 862-1299

*Department of Pathology, 208 Reynolds Medical Building, College Station, TX 77843-1114

Publication History

  1. Issue published online: 14 OCT 2002
  2. Article first published online: 14 OCT 2002
  3. Manuscript Accepted: 4 JUN 2002
  4. Manuscript Received: 5 FEB 2002

Funded by

  • NIH (NHLBI). Grant Number: HL59373
  • Texas Higher Education Coordinating Board. Grant Number: 89-57-2001
  • NRSA. Grant Number: F32 HL69603

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (2892K)

LITERATURE CITED

  • Adams JC. 2001. Thrombospondins: multifunctional regulators of cell interactions. Annu Rev Cell Dev Biol 17: 25–51.
  • Akhtar N, Hotchin NA. 2001. Rac1 Regulates adherens junctions through endocytosis of E-cadherin. Mol Biol Cell 12: 847–862.
  • Allt G, Lawrenson JG. 2001. Pericytes: cell biology and pathology. Cell Tissues Organs 169: 1–11.
  • Anderson RG. (1998) The caveolae membrane system. Annu Rev Biochem 67: 199–225.
  • Bacharach E, Itin A, Keshet E. 1998. Apposition-dependent induction of plasminogen activator type I expression: a mechanism for balancing pericellular proteolysis during angiogenesis. Blood 92: 939–945.
  • Bajou K, Noel A, Gerard RD, Masson V, Brunner N, Holst-Hansen C, Skobe M, Fusenig NE, Carmeliet P, Collen D, Foidart JM. 1998. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 4: 923–928.
  • Bajou K, Masson V, Gerard RD, Schmitt PM, Albert V, Praus M, Lund LR, Frandsen TL, Brunner N, Dano K, Fusenig NE, Weidle U, Carmeliet G, Loskutoff D, Collen D, Carmeliet P, Foidart JM, Noel A. 2001. The plasminogen activator PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol 152: 777–784.
  • Bauer J, Margolis M, Schreiner C, Edgell CJ, Azizkhan J, Lazarowski E, Juliano RL. 1992. In vitro model of angiogenesis using a human endothelium-derived permanent cell line: contributions of induced gene expression, G-proteins and integrins. J Cell Physiol 153: 437–449.
    Direct Link:
  • Bayless KJ, Salazar R, Davis GE. 2000. RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the αvβ3 and α5β1 integrins. Am J Pathol 156: 1673–1683.
  • Bayless KJ, Davis GE. 2002. The Cdc42 and Rac1 GTPases are required for capillary lumen formation in three-dimensional extracellular matrices. J Cell Sci 115: 1123–1136.
  • Beitel GJ, Krasnow MA. 2000. Genetic control of epithelial tube size in the Drosophila tracheal system. Development 127: 3271–3282.
  • Bell SE, Mavila A, Salazar R, Bayless KJ, Kanagala S, Maxwell SA, Davis GE. 2001. Differential gene expression during capillary morphogenesis in three-dimensional collagen matrices: regulated expression of novel and known genes involved in basement membrane matrix assembly, cell cycle regulation, cellular differentiation and G-protein signaling. J Cell Sci 114: 2755–2733.
  • Benjamin LE, Keshet E. 1997. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 94: 8761–8766.
  • Benjamin LE, Golijanin D, Itin A, Pode D, Keshet E. 1999. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103: 159–165.
  • Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D. 2000. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2: 737–744.
  • Bermak JC, Li M, Bullock C, Zhou QY. 2001. Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein. Nat Cell Biol 3: 492–498.
  • Bishop AL, Hall A. 2000. Rho GTPases and their effector proteins. Biochem J 348: 241–255.
  • Bloch W, Forsberg E, Lentini S, Brakebusch C, Martin K, Krell HW, Weidle UH, Addicks K, Fassler R. 1997. Beta 1 integrin is essential for teratoma growth and angiogenesis. J Cell Biol 139: 265–278.
  • Bonanno E, Iurlaro M, Madri JA, Nicosia RF. 2000. Type IV collagen modulates angiogenesis and neovessel survival in the rat aorta model. In Vitro Cell Dev Biol Anim 36: 336–340.
  • Bowman EP, Campbell JJ, Druey KM, Scheschonka A, Kehrl JH, Butcher EC. 1998. Regulation of chemotactic and proadhesive responses to chemoattractant receptors by RGS (regulator of G-protein signaling) family members. J Biol Chem 273: 28040–28048.
  • Boyer B, Valles AM, Edme N. 2000. Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 60: 1091–1999.
  • Bradley KA, Mogridge J, Mourez M, Collier JR, Young RA. 2001. Identification of the cellular receptor for anthrax toxin. Nature 414: 225–229.
  • Brooks PC, Clark RA, Cheresh DA. 1994. Requirement of vascular integrin αvβ3 for angiogenesis. Science 264: 569–571.
  • Browder T, Folkman J, Pirie-Shepherd S. 2000. The hemostatic system as regulator of angiogenesis. J Biol Chem 275: 1521–1524.
  • Brown PO, Botstein D. 1999. Exploring the new world of the genome with DNA microarrays. Nat Genet 21: 33–37.
  • Buechner M, Hall DH, Bhatt H, Hedgecock EM. 1999. Cystic canal mutants in Caenorhabditis elegans are defective in the apical membrane domain of the renal (excretory) cell. Dev Biol 214: 227–241.
  • Cardelli J. 2001. Phagocytosis and macropinocytosis in Dictyostelium: phosphoinositide-based processes, biochemically distinct. Traffic 2: 311–320.
    Direct Link:
  • Carlson TR, Feng Y, Maisonpierre PC, Mrksick M, Morla A. 2001. Direct cell adhesion to the angiopoietins by integrins. J Biol Chem 276: 26516–26525.
  • Carmeliet P, Jain RK. 2000. Angiogenesis in cancer and other diseases. Nature 407: 249–257.
  • Carmeliet P, Luttun A. 2001. The emerging role of the bone marrow-derived stem cells in (therapeutic) angiogenesis. Thromb Haem 86: 289–297.
  • Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono, F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG. 2001. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7: 575–583.
  • Caron E, Hall A. 1998. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 282: 1717–1721.
  • Chimini G, Chavrier P. 2000. Function of Rho family of proteins in actin dynamics during phagocytosis and engulfment. Nat Cell Biol 2: E191–E196.
  • Clark ER, Clark EL. 1939. Microscopic observations on the growth of blood capillaries in the living mammal. Am J Anat 64: 251–301.
    Direct Link:
  • Clark RAF. 1996. Wound repair: overview and general considerations. In: ClarkRAF, editor. The molecular and cellular biology of wound repair. New York: Plenum Press. p 3–50.
  • Cohen B, Barkan D, Levy Y, Goldberg I, Fridman E, Kopolovic J, Rubinstein M. 2001. Leptin induces angiopoietin-2 expression in adipose tissues. J Biol Chem 276: 7697–7700.
  • Colombatti A, Bonaldo P. 1991. The superfamily of proteins with von Willebrand factor type A-like domains: one theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms. Blood 77: 2305–2315.
  • Conway EM, Collen D, Carmeliet P. 2001. Molecular mechanisms of blood vessel growth. Cardiovasc Res 49: 507–521.
  • Daub H, Gavaert K, Vandekerchkhove J, Sobel A, Hall A. 2001. Rac/Cdc42 and p65PAK regulate the microtubule-destabilizing protein stathmin through phosphorylation and serine 16. J Biol Chem 276: 1677–1680.
  • Davis GE, Camarillo CW. 1995. Regulation of endothelial cell morphogenesis by integrins, mechanical forces, and matrix guidance pathways. Exp Cell Res 216: 113–123.
  • Davis GE, Camarillo CW. 1996. An α2β1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix. Exp Cell Res 224: 39–51.
  • Davis GE, Bayless KJ, Davis MJ, Meininger GA. 2000a. Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am J Pathol 156: 1489–1498.
  • Davis GE, Black SM, Bayless KJ. 2000b. Capillary morphogenesis during endothelial cell invasion of three-dimensional collagen matrices. In Vitro Cell Dev Biol Anim 36: 513–519.
  • Davis GE, Pintar Allen KA, Salazar R, Maxwell SA. 2001. Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. J Cell Sci 114: 917–930.
  • Davis GE, Bayless KJ. 2003. An integrin and Rho GTPase-dependent pinocytic vacuole mechanism controls capillary lumen formation in collagen and fibrin matrices. Microcirculation (in press).
  • Deblandre GA, Wettstein DA, Koyano-Nakagawa N, Kintner C. 1999. A two step mechanism generates the spacing pattern of the ciliated cells in the skin of Xenopus embryos. Development 126: 4715–4728.
  • Denton CP, Abraham DJ. 2001. Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis. Curr Opin Rheumatol 13: 505–511.
  • DeRisi JL, Iyer VR, Brown PO. 1997. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278: 680–686.
  • DeVries L, Zheng B, Fischer T, Elenko E, Farquhar MG. 2000. The regulator of G protein signaling family. Annu Rev Pharmacol Toxicol 40: 235–271.
  • Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ. 1995. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knockout mice. Development 121: 1845–1854.
  • Djonov V, Schmid M, Tschanz SA, Burri PH. 2000. Intussceptive angiogenesis: its role in embryonic vascular network formation. Circ Res 86: 286–292.
  • Drake CJ, Brandt SJ, Trusk TC, Little CD. 1997. Tal/Scl is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis. Dev Biol 192: 17–30.
  • Drake CJ, Little CD. 1999. VEGF and vascular fusion: implications for normal and pathological vessels. J Histochem Cytochem 47: 1351–1355.
  • Drake CJ, Fleming PA. 2000. Vasculogenesis in the day 6. 5 to 9.5 mouse embryo. Blood 95: 1671–1679.
  • Dvorak AM, Feng D. 2001. The vesiculo-vacuolar organelle (VVO). A new endothelial cell permeability organelle. J Histochem Cytochem 49: 419–432.
  • Dyson SE, Jones DG, Kendrick WL. 1976. Some observations on the ultrastructure of developing rat cerebral capillaries. Cell Tissue Res 173: 529–542.
  • Erickson AC, Couchman JR. 2000. Still more complexity in mammalian basement membranes. J Histochem Cytochem 48: 1291–1306.
  • Ernfors P. 2001. Local and target-derived actions of neurotrophins during peripheral nervous system development. Cell Mol Life Sci 58: 1036–1044.
  • Fan WH, Pech M, Karnovsky MJ. 2000. Connective tissue growth factor (CTGF) stimulates vascular smooth muscle cell growth and migration in vitro. Eur J Cell Biol 79: 915–923.
  • Folkman J, Haudenschild C. 1980. Angiogenesis in vitro. Nature 288: 551–556.
  • Folkman J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27–31.
  • Folkman J. 1997. Angiogenesis and angiogenesis inhibition: an overview. EXS 79: 1–8.
  • Garrett WS, Chen LM, Kroschewski R, Ebersold M, Turley S, Trombetta S, Galan JE, Mellman I. 2000. Developmental control of endocytosis in dendritic cells by Cdc42. Cell 102: 325–334.
  • Geiger B, Bershadsky A, Pankov R, Yamada KM. 2001. Transmembrane crosstalk between the extracellular matrix-cytoskeleton. Nat Rev Mol Cell Biol 2: 793–805.
  • Giancotti FG, Ruoslahti E. 1999. Integrin signaling. Science 285: 1028–1032.
  • Glienke J, Schmitt AO, Pilarsky C, Hinzmann B, Weib B, Rosenthal A, Thierauch KH. 2000. Differential gene expression by endothelial cells in distinct angiogenic states. Eur J Biochem 267: 2820–2830.
    Direct Link:
  • Goede V, Schmidt T, Kimmina S, Kozian D, Augustin HG. 1998. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab Invest 78: 1385–1394.
  • Goepfert C, Imai M, Brouard S, Csizmadia E, Kaczmarek E, Robson SC. 2000. CD39 modulates endothelial cell activation and apoptosis. Mol Med 6: 591–603.
  • Gonias SL, Carmichael A, Mettenburg JM, Roadcap DW, Irvin WP, Webb DJ. 2000. Identical or overlapping sequences in the primary structure of human alpha (2)-macroglobulin are responsible for the binding of nerve growth factor-beta, platelet-derived growth factor-BB, and transforming growth factor-beta. J Biol Chem 275: 5826–5831.
  • Goode BL, Drubin DG, Barnes F. 2000. Functional cooperation between the microtubule and actin cytoskeletons. Curr Opin Cell Biol 12: 63–71.
  • Greenberg S. 1995. Signal transduction of phagocytosis. Trends Cell Biol 5: 93–99.
  • Grotendorst GR. 1997. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 8: 171–179.
  • Guldner FH, Wolff JR. 1973. Seamless endothelia as indicators of capillaries developed from sprouts. Bibl Anat 12: 120–123.
  • Haas TL, Madri JA. 1999. Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: implications for angiogenesis. Trends Cardiovasc Med 9: 70–77.
  • Hacohen N, Kramer S, Sutherland D, Hiromi Y, Krasnow MA. 1998. Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 92: 253–263.
  • Hall A, Nobes CD. 2000. Rho GTPases: molecular switches that control the organization and dynamics of the actin cytoskeleton. Philos Trans R Soc Lond B 355: 965–970.
  • Hanahan D. 1997. Signaling vascular morphogenesis and maintenance. Science 277: 48–50.
  • Hardt B, Bause E. 2002. Lysine can be replaced by histidine but not by arginine as the ER retrieval motif for type I membrane proteins. Biochem Biophys Res Commun 291: 751–757.
  • Hawes BE, Kil E, Green B, O'Neill K, Fried S, Graziano MP. 2000. The melanin-concentrating hormone receptor couples to multiple G proteins to activate diverse intracellular signaling pathways. Endocrinology 141: 4525–4532.
  • He CS, Wilhelm SM, Pentland AP, Marmer BL, Grant GA, Eisen AZ, Goldberg GI. 1989. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 86: 2632–2636.
  • Hedin U, Roy J, Tran PK, Lundmark K, Rahman A. 1999. Control of smooth muscle cell proliferation—the role of the basement membrane. Thromb Haem 1 (Suppl): 23–26.
  • Hellstrom A, Perruzzi C, Ju M, Engstrom E, Hard AL, Liu JL, Albertsson-Wikland K, Carlsson B, Niklasson A, Sjodell L, LeRoith D, Senger DR, Smith LE. 2001b. Low IGF-1 suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA 98: 5804–5808.
  • Hellstrom M, Gerhardt H, Kalen M, Li X, Eriksson U, Wolburg H, Betsholtz C. 2001a. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153: 543–553.
  • Herman MP, Sukhova GK, Kisiel W, Foster D, Kehry MR, Libby P, Schonbeck U. 2001. Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J Clin Invest 107: 1117–1126.
  • Hiraoka N, Allen E, Apel IJ, Gyeto MR, Weiss SJ. 1998. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95: 365–377.
  • Hirschi KK, Rohovsky SA, D'Amore PA. 1998. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 141: 805–814.
  • Holash J, Wiegand SJ, Yancopoulos GD. 1999. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18: 5356–5362.
  • Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ. 2000. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol 149: 1309–1323.
  • Ikeya T, Hayashi S. 1999. Interplay of Notch and FGF signaling restricts cell fate and MAPK activation in the Drosophila trachea. Development 126: 4455–4463.
  • Ilan N, Mahooti S, Madri JA. 1998. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. J Cell Sci 111: 3621–3631.
  • Ilan N, Cheung L, Pinter E, Madri JA. 2000. Platelet-endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation. J Biol Chem 275: 21435–21443.
  • Inada H, Togashi H, Nakamura Y, Kaibuchi K, Nagata K, Inagaki M. 1999. Balance between activities of Rho kinase and type 1 protein phosphatase modulates turnover of phosphorylation and dynamics of desmin/vimentin filaments. J Biol Chem 274: 34932–34939.
  • Ingber D, Folkman J. 1988. Inhibition of angiogenesis through modulation of collagen metabolism. Lab Invest 59: 44–51.
  • Iruela-Arispe ML, Hasselaar P, Sage EH. 1991. Differential expression of extracellular proteins is correlated with angiogenesis in vitro. Lab Invest 64: 174–186.
  • Jeffrey JJ. 1998. Interstitial collagenases. In: ParksWC, MechamRP, editors. Matrix metalloproteinases. San Diego: Academic Press. p 15–42.
  • Kadoya Y, Salmivirta K, Talts JF, Kadoya K, Mayer U, Timpl R, Ekblom P. 1997. Importance of nidogen binding to laminin gamma1 for branching epithelial morphogenesis of the submandibular gland. Development 124: 683–691.
  • Kahn J, Mehraban F, Ingle G, Xin X, Bryant JE, Vehar G, Schoenfeld J, Grimaldi CJ, Peale F, Draksharapu A, Lewin DA, Gerritsen ME. 2000. Gene expression profiling in an in vitro model of angiogenesis. Am J Pathol 156: 1887–1900.
  • Kaibuchi K, Kuroda S, Amano M. 1999. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 68: 459–468.
  • Kamada S, Kusano H, Fujita H, Ohtsu M, Koya RC, Kuzumaki N, Tsujimoto Y. 1998. A cloning method for caspase substrates that uses the yeast two-hybrid system: cloning of the antiapoptotic gene gelsolin. Proc Natl Acad Sci USA 95: 8532–8537.
  • Kim S, Bell K, Mousa SA, Varner JA. 2000. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am J Pathol 156: 1345–1362.
  • Kiosses WB, Daniels RH, Otey C, Bokoch GM, Schwartz MA. 1999. A role for p21-activated kinase in endothelial cell migration. J Cell Biol 147: 831–843.
  • Kiosses WB, Hood J, Yang S, Gerritsen ME, Cheresh DA, Alderson N, Schwartz MA. 2002. A dominant-negative p65 PAK peptide inhibits angiogenesis. Circ Res 90: 697–702.
  • Klinkenberg M, Van Huffel S, Heyninck K, Beyaert R. 2001. Functional redundancy of the zinc fingers of A20 for inhibition of NF-kappaB activation and protein-protein interactions. FEBS Lett 498: 93–97.
  • Koepp DM, Harper JW, Elledge SJ. 1999. How the cyclin became a cyclin: regulated proteolysis in the cell cycle. Cell 97: 431–434.
  • Kokorine I, Marbaix E, Henriet P, Okada Y, Donnez J, Eeckhout Y, Courtoy PJ. 1996. Focal cellular origin and regulation of interstitial collagenase (matrix metalloproteinase-1) are related to menstrual breakdown in the human endometrium. J Cell Sci 109: 151–160.
  • Konerding MA, van Ackern C, Steinberg F, Streffer C. 1992. Combined morphological approaches in the study of network formation in tumor angiogenesis. In: SteinerR, WeiszPB, LangerR, editors. Angiogenesis. Basel: Birkhauser Verlag/Switzerland. p 40–58.
  • Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ, Williams LT. 1997. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278: 294–298.
  • Kyriakides TR, Zhu YH, Smith LT, Bain SD, Yang Z, Lin MT, Danielson KG, Iozzo RV, LaMarca M, McKinney CE, Ginns EI, Bornstein P. 1998. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 140: 419–430.
  • Lanford PJ, Lan Y, Jiang R, Lindsell C, Weinmaster G, Gridley T, Kelley MW. 1999. Notch signaling pathway mediates hair cell development in mammalian cochlea. Nat Genet 21: 289–292.
  • Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, Ma A. 2000. Failure to regulate TNF-induced NF-kappaB and cell death response in A20-deficient mice. Science 289: 2350–2354.
  • Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, Kluk M, Volpi M, Sha'afi RI, Hla T. 1999. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99: 301–312.
  • Lee SH, Schloss DJ, Jarvis L, Krasnow MA, Swain JL. 2001. Inhibition of angiogenesis by a mouse sprouty protein. J Biol Chem 276: 4128–4133.
  • Lefebvre O, Sorokin L, Kedinger M, Simon-Assmann P. 1999. Developmental expression and cellular origin of the laminin alpha2, alpha4, and alpha5 chains in the intestine. Dev Biol 210: 135–150.
  • Li DY, Sorenson LK, Brooke BS, Urness LD, Davis EC, Taylor DG, Boak BB, Wendel DP. 1999. Defective angiogenesis in mice lacking endoglin. Science 284: 1534–1537.
  • Lin HH, Yang TP, Jiang ST, Yang HY, Tang MJ. 1999. Bcl-2 overexpression prevents apoptosis-induced Madin-Darby canine kidney simple epithelial cyst formation. Kidney Int 55: 168–178.
  • Linder V, Booth C, Prudovsky I, Small D, Maciag T, Liaw L. 2001. Members of the Jagged/Notch gene families are expressed in injured arteries and regulate cell phenotype via alterations in cell matrix and cell-cell interaction. Am J Pathol 159: 875–883.
  • Lindsell CE, Boulter J, diSibio G, Gossler A, Weinmaster G. 1996. Expression patterns of Jagged, Delta1, Notch1, Notch2, and Notch3 genes identify ligand-receptor pairs that may function in neural development. Mol Cell Neurosci 8: 14–27.
  • Lipschutz JH, Guo W, O'Brien LE, Nguyen YH, Novick P, Mostov KE. 2000. Exocyst is involved in cystogenesis and tubulogenesis and acts by modulating synthesis and delivery of basolateral plasma membrane and secretory proteins. Mol Biol Cell 11: 4259–4275.
  • Lipschutz JH, Mostov KE. 2002. Exocytosis: the many masters of the exocyst. Curr Biol 12: R212–214.
  • Liu Y, Stack SM, Lakka SS, Khan AJ, Woodley DT, Rao JS, Rao CN. 1999. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine proteinase inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin. Arch Biochem Biophys 370: 112–118.
  • Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, Hobson JP, Rosenfeldt HM, Nava VE, Chae SS, Lee MJ, Liu CH, Hla T, Spiegel S, Proia RL. 2000. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 106: 951–961.
  • Llimargas M. 1999. The Notch pathway helps to pattern the tips of the Drosophila tracheal branches by selecting cell fates. Development. 126: 2355–2364.
  • Lund LR, Romer J, Bugge TH, Nielsen BS, Frandsen TL, Degen JL, Stephens RW, Dano K. 1999. Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J 18: 4645–4656.
  • Maeshima Y, Sudhakar A, Lively JC, Ueki K, Kharbanda S, Kahn CR, Sonenberg N, Hynes RO, Kalluri R. 2002. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science 295: 140–143.
  • Mandriota SJ, Pepper MS. 1998. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 83: 852–859.
  • Maragoudakis ME, Sarmonika M, Panoutsacopoulou M. 1988. Inhibition of basement membrane synthesis prevents angiogenesis. J Pharmacol Exp Therapeut 244: 729–733.
  • Marbaix E, Kokorine I, Donnez J, Eeckhout Y, Courtoy PJ. 1996. Regulation and restricted expression of interstitial collagenase suggest a pivotal role in the initiation of menstruation. Hum Reprod 11 (Suppl 2): 134–143.
  • Martin KJ, Pardee AB. 1999. Principles of differential display. Methods Enzymol 303: 234–258.
  • Marx M, Perlmutter RA, Madri JA. 1994. Modulation of platelet-derived growth factor receptor expression in microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 93: 131–139.
  • Maxwell SA, Davis GE. 2000. Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines. Proc Natl Acad Sci USA 97: 13009–13014.
  • Mentlein R. 1999. Dipeptidyl-peptidase IV (CD26)—role in the inactivation of regulatory peptides. Regul Pept 85: 9–24.
  • Meriane M, Mary S, Comunale F, Vifnal E, Fort P, Gauthier-Rouviere C. 2000. Cdc42Hs and Rac1 GTPases induce collapse of the vimentin intermediate filament network. J Biol Chem 275: 33046–33052.
  • Mettouchi A, Klein S, Guo W, Lopez-Lago M, Lemichez E, Westwick JK, Giancotti FG. 2001. Integrin-specific activation of Rac controls progression through the G(1) phase of the cell cycle. Mol Cell 8: 115–127.
  • Metzger RJ, Krasnow M. 1999. Genetic control of branching morphogenesis. Science 284: 1635–1639.
  • Meyer GT, Matthias LJ, Noack L, Vadas MA, Gamble JR. 1997. Lumen formation during angiogenesis in vitro involves phagocytic activity, formation and secretion of vacuoles, cell death, and capillary tube remodelling by different populations of endothelial cells. Anat Rec 249: 327–340.
    Direct Link:
  • Miao H-Q, Soker S, Feiner L, Alonso JL, Raper JA, Klagsbrun M. 1999. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial cell growth factor-165. J Cell Biol 146: 233–241.
  • Miao HQ, Klagsbrun M. 2000. Neuropilin is a mediator of angiogenesis. Cancer Metastasis Rev 19: 29–37.
  • Miner JH, Cunningham J, Sanes JR. 1998. Roles for laminin in embryogenesis: exencephaly, syndactyly, and placentopathy in mice lacking the laminin alpha5 chain. J Cell Biol 143: 1713–1723.
  • Mitchell MS, Kan-Mitchell J, Minev B, Edman C, Deans RJ. 2000. A novel melanoma gene (MG50) encoding the interleukin 1 receptor antagonist and six epitopes recognized by human cytolytic T lymphocytes. Cancer Res 60: 6448–6456.
  • Montesano R, Orci L. 1985. Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 42: 469–477.
  • Montesano R, Orci L. 1988. Intracellular diaphragmed fenestrae in cultured capillary endothelial cells. J Cell Sci 89: 441–447.
  • Montesano R, Matsumoto K, Nakamura T, Orci L. 1991. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67: 901–908.
  • Montesano R. 1992. Regulation of angiogenesis in vitro. Eur. J Clin Invest 22: 504–515.
    Direct Link:
  • Montesano R, Pepper MS, Vassalli JD, Orci L. 1992. Modulation of angiogenesis in vitro. EXS 61: 129–136.
  • Montesano R, Soriano JV, Pepper MS, Orci L. 1997. Induction of epithelial branching tubulogenesis in vitro. J Cell Physiol 173: 152–161.
    Direct Link:
  • Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I, Rifkin DB. 1997. Latent transforming growth factor-beta: structural features and mechanisms of activation. Kidney Int 51: 1376–1382.
  • Nakajima Y, Mironov V, Yamagishi T, Nakamura H, Markwald RR. 1997. Expression of smooth muscle alpha-actin in mesenchymal cells during formation of avian endocardial cushion tissue: a role for transforming growth factor beta3. Dev Dyn 209: 296–309.
    Direct Link:
  • Nelson RE, Fessler LI, Takagi Y, Blumberg B, Keene DR, Olson PF, Parker CG, Fessler JH. 1994. Peroxidasin: a novel enzyme-matrix protein of Drosophila development. EMBO J 13: 3438–3447.
  • Nicosia RF, Tchao R, Leighton J. 1982. Histotypic angiogenesis in vitro: light microscopic, ultrastructural, and radioautographic studies. In Vitro 18: 538–549.
  • Nicosia RF, Madri JA. 1987. The microvascular extracellular matrix. Developmental changes during angiogenesis in the aortic ring-plasma clot model. Am J Pathol 128: 78–90.
  • Nicosia RF, Ottinetti A. 1990. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest 63: 115–122.
  • Nicosia RF, Villaschi S. 1999. Autoregulation of angiogenesis by cells of the vessel wall. Int Rev Cytol 185: 1–43.
  • Nobes CD, Hall A. 1995. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81: 53–62.
  • O'Brien LE, Jou TS, Pollack AL, Zhang Q, Hansen SH, Yurchenco P, Mostov KE. 2001. Rac1 orientates epithelial apical polarity through effects on basolateral laminin assembly. Nat Cell Biol 3: 831–838.
  • O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. 1994. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma. Cell 79: 315–328.
  • O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. 1997. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277–285.
  • Paik JH, Chae SS, Lee MJ, Thangada S, Hla T. 2001. Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of Edg-1 and Edg-3 receptors and Rho-dependent activation of alphavbeta3 and beta1-containing integrins. J Biol Chem 276: 11830–11837.
  • Palazzo AF, Cook TA, Alberts AS, Gundersen GG. 2001. mDia mediates Rho-regulated formation and orientation of stable microtubules. Nat Cell Biol 3: 723–729.
  • Patan S. 2000. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J Neurooncol 50: 1–15.
  • Peale FV, Gerritsen ME. 2001. Gene profiling techniques and their application in angiogenesis and vascular development. J Pathol 195: 7–19.
    Direct Link:
  • Pellegrini P, Contasta I, Berghella AM, Gargano E, Mammarella C, Adorno D. 2000. Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer. Cancer Immunol Immunother 49: 388–394.
  • Pepper MS, Montesano R. 1990. Proteolytic balance and capillary morphogenesis. Cell Diff Dev 32: 319–327.
  • Pepper MS, Ferrara N, Orci L, Montesano R. 1992. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189: 824–831.
  • Pepper MS. 1997. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8: 21–43.
  • Pepper MS. 2001. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21: 1104–1117.
  • Perkins SJ, Hinshelwood J, Edwards YJ, Jenkins PV. 1999. Structural and functional modeling of von Willebrand factor type A domains in complement and coagulation. Biochem Soc Trans 27: 815–820.
  • Pinsky DJ, Liao H, Lawson CA, Yon SF, Chen J, Carmeliet P, Luskutoff DJ, Stern DM. 1998. Coordinated induction of plasminogen activator inhibitor-I (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. J Clin Invest 102: 919–928.
  • Pollack AL, Barth AI, Altschuler Y, Nelson WJ, Mostov KE. 1997. Dynamics of beta-catenin interactions with APC protein regulate epithelial tubulogenesis. J Cell Biol 137: 1651–1662.
  • Prehoda KE, Scott JA, Mullins RD, Lim WA. 2000. Integration of multiple signals through cooperative regulation of the N-WASP-Arp2/3 complex. Science 290: 801–806.
  • Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP. 1999. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 1999: 274: 13066–13076.
  • Rao CN, Reddy P, Liu Y, O'Toole E, Reeder D, Foster DC, Kisiel W, Woodley DT. 1996. Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2. Arch Biochem Biophys 335: 82–92.
  • Reich A, Sapir A, Shilo B. 1999. Sprouty is a general inhibitor of receptor tyrosine kinase signaling. Development 126: 4139–4147.
  • Reinhard M, Jarchau T, Walter U. 2001. Actin-based motility: stop and go with Ena/VASP proteins. Trends Biochem Sci 26: 243–249.
  • Renaud O, Simpson P. 2001. Scabrous modifies epithelial cell adhesion and extends the range of lateral signaling during development of the spaced bristle pattern in Drosophila. Dev Biol 240: 361–376.
  • Ridley AJ, Hall A. 1992. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70: 389–399.
  • Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A. 1992. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70: 401–410.
  • Ridley AJ. 2001a. Rho family proteins: coordinating cell responses. Trends Cell Biol 11: 471–477.
  • Ridley AJ. 2001b. Rho proteins: linking signaling with membrane trafficking. Traffic 2: 303–310.
    Direct Link:
  • Risau W, Flamme I. 1995. Vasculogenesis. Annu Rev Cell Dev Biol 11: 73–91.
  • Rohatgi R, Ma L, Miki H, Lopez M, Kirchhausen T, Takenawa T, Kirschner MW. 1999. The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell 97: 221–231.
  • Ruggiero D, Lecomte M, Michoud E, Lagarde M, Wiernsperger N. 1997. Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy. Diabetes Metab 23: 30–42.
  • Rupp PA, Little CD. 2001. Integrins in vascular development. Circ Res 89: 566–572.
  • Sage EH. 1997. Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis. Trends Cell Biol 7: 182–186.
  • Salazar R, Bell SE, Davis GE. 1999. Coordinate induction of the actin cytoskeletal regulatory proteins gelsolin, vasodilator-stimulated phosphoprotein, and profilin during capillary morphogenesis in vitro. Exp Cell Res 249: 22–32.
  • Samakovlis C, Hacohen N, Manning G, Sutherland DC, Guillemin K, Krasnow MA. 1996. Development of the Drosophila tracheal system occurs by a series of morphologically distinct but genetically coupled branching events. Development 122: 1395–1407.
  • Sanes JR, Lichtman JW. 2001. Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat Rev Neurosci 2: 791–805.
  • Sastry SK, Burridge K. 2000. Focal adhesions: a nexus for intracellular signaling and cytoskeletal dyamics. Exp Cell Res 261: 25–36.
  • Sato Y, Tsuboi R, Lyons R, Moses H, Rifkin DB. 1990. Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol 111: 757–763.
  • Savagner P. 2001. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 23: 912–923.
    Direct Link:
  • Schwartz MA, Shattil S. 2000. Signaling networks linking integrins and Rho family GTPases. Trends Biochem Sci 25: 388–391.
  • Schwartz MA, Assoian RK. 2001. Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J Cell Sci 114: 2553–2560.
  • Selvarajan S, Lund LR, Takeuchi T, Craik CS, Werb Z. 2001. A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation. Nat Cell Biol 3: 267–274.
  • Senger DR. 1996. Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Am J Pathol 149: 1–7.
  • Senger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, Detmar M. 1997. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci USA 94: 13612–13617.
  • Senger DR, Perruzzi CA, Streit M, Koteliansky VE, deFougerolles AR, Detmar M. 2002. The alpha(1) beta(1) and alpha(2) beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am J Pathol 160: 195–204.
  • Sephel GC, Kennedy R, Kudravi S. 1996. Expression of capillary basement membrane components during sequential phases of wound angiogenesis. Matrix Biol 15: 263–279.
  • Settleman J. 2001. Rac 'n Rho: the music that shapes a developing embryo. Dev Cell 1: 321–331.
  • Shattil SJ, Ginsberg MH. 1997. Integrin signaling in vascular biology. J Clin Invest 100: S91–S95.
  • Sima AA, Chakrabarti S, Garcia-Salinas R, Basu PK. 1985. The BB-rat- an authentic model of human diabetic retinopathy. Curr Eye Res 4: 1087–1092.
  • Smola H, Stark HJ, Thiekotter G, Mirancea N, Krieg T, Fusenig NE. 1998. Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in organotypic skin culture. Exp Cell Res 239: 399–410.
  • Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. 1998. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92: 735–745.
  • Soleimani M, Burnham CE. 2001. Na+:HCO3– cotransporters (NBC): cloning and characterization. J Membr Biol 183: 71–84.
  • Speidel CC. 1933. Studies of living nerves: activities of ameboid growth cones, sheath cells and myelin segments, as revealed by prolonged observation of individual nerve fibers in frog tadpoles. Am J Anat 52: 1–75.
    Direct Link:
  • St. Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW. 2000. Genes expressed in human tumor endothelium. Science 289: 1197–1202.
  • Sternlicht MD, Werb Z. 2001. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463–516.
  • Streit M, Riccardi L, Velasco P, Brown LF, Hawighorst T, Bornstein P, Detmar M. 1999. Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc Natl Acad Sci USA 96: 14888–14893.
  • Stromhaug PE, Klionsky DJ. 2001. Approaching the molecular mechanism of autophagy. Traffic 2: 524–531.
    Direct Link:
  • Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87: 1171–1180.
  • Swanson JA, Watts C. 1995. Macropinocytosis. Trends Cell Biol 5: 424–428.
  • Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, Bissell MJ, Werb Z. 1994. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 125: 681–693.
  • Takai Y, Sasaki T, Matozaki T. 2001. Small GTP-binding proteins. Physiol Rev 81: 153–208.
  • Talhouk RS, Bissell MJ, Werb Z. 1992. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol 118: 1271–1282.
  • Tzuu-Shuh J, Nelson WJ. 1998. Effects of regulated expression of mutant RhoA and Rac1 small GTPases on the development of epithelial (MDCK) cell polarity. J Cell Biol 142: 85–100.
  • Tzuu-Shuh J, Schneeberger EE, Nelson WJ. 1998. Structural and functional regulation of tight junctions by RhoA and Rac1 small GTPases. J Cell Biol 142: 101–115.
  • Urness LD, Sorenson LK, Li DY. 2000. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26: 328–331.
  • Uyttendaele H, Closson V, Wu G, Roux F, Weinmaster G, Kitajewski J. 2000. Notch4 and jagged-1 induce microvessel differentiation of rat brain endothelial cells. Microvasc Res 60: 91–103.
  • Vega-Salas DE, Salas PJI, Rodriguez-Boulan E. 1987. Modulation of the expression of an apical plasma membrane protein of Madin-Darby canine kidney epithelial cells: cell-cell interactions control the appearance of a novel intracellular storage compartment. J Cell Biol 104: 1249–1259.
  • Vega-Salas DE, Salas PJI, Rodriguez-Boulan E. 1988. Exocytosis of vacuolar apical compartment (VAC): a cell-cell contact controlled mechanism for the establishment of the apical plasma membrane domain in epithelial membrane domain in epithelial cells. J Cell Biol 107: 1717–1728.
  • Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. 1995. Serial analysis of gene expression. Science 270: 484–487.
  • Vernon RB, Angello JC, Iruela-Arispe ML, Lane TF, Sage EH. 1992. Reorganization of basement membrane matrices by cellular traction promotes the formation of cellular networks in vitro. Lab Invest 66: 536–547.
  • Vernon RB, Sage EH. 1995. Between molecules and morphology: extracellular matrix and the creation of vascular form. Am J Pathol 147: 873–883.
  • Vernon RB, Sage EH. 1999. A novel, quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matrices. Microvasc Res 57: 118–133.
  • Volkov Y, Long A, McGrath S, Ni Eidhin D, Kelleher D. 2001. Crucial importance of PKC-beta(I) in LFA-mediated locomotion of activated T cells. Nat Immunol 2: 508–514.
  • Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93: 411–422.
  • Wagner RC. 1980. Endothelial cell embryology and growth. Adv Microcirc 9: 45–75.
  • Wang HU, Chen ZF, Anderson DJ. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93: 741–753.
  • Weaver VM, Bissell MJ. 1999. Functional culture models to study mechanisms governing apoptosis in normal and malignant mammary epithelial cells. J Mamm Gland Biol Neoplasia 4: 193–201.
  • Werb Z, Sympson CJ, Alexander CM, Thomasset N, Lund LR, MacAuley A, Ashkenas J, Bissell MJ. 1996. Extracellular matrix remodeling and the regulation of epithelial-stromal interactions during differentiation and involution. Kidney Int 49 ()Suppl 54: S68–S74.
  • Werb Z, Vu TH, Rinkenberger JL, Coussens LM. 1999. Matrix-degrading proteases and angiogenesis during development and tumor formation. APMIS 107: 11–18.
    Direct Link:
  • Wilkinson DG. 2001. Multiple roles of EPH receptors and ephrins in neural development. Nat Rev Neurosci 2: 155–164.
  • Wojciak-Stothard B, Potempa S, Eichholtz T, Ridley AJ. 2001. Rho and Rac but not Cdc42 regulate endothelial cell permeability. J Cell Sci 114: 1343–1355.
  • Wolff JR, Bar T. 1972. ‘Seamless’ endothelia in brain capillaries during development of the rat's cerebral cortex. Brain Res 41: 17–24.
  • Wong ES, Lim J, Low BC, Chen Q, Guy CR. 2000. Evidence for direct interaction between sprouty and cbl. J Biol Chem 276: 5866–5875.
  • Xu J, Rodriguez D, Petitclerc E, Kim JJ, Masanori H, Moon YS, Davis GE, Brooks PC. 2001. Proteolytic exposure of a cryptic site within collagen type-IV is required for angiogenesis and tumor growth in vivo. J Cell Biol 154: 1069–1080.
  • Yamada E, Tobe T, Yamada H, Okamoto N, Zack DJ, Werb Z, Soloway PD, Campochiaro PA. 2001. TIMP-1 promotes VEGF-induced neovascularization in the retina. Histol Histopathol 16: 87–97.
  • Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. 2000. Vascular-specific growth factors and blood vessel formation. Nature 407: 242–248.
  • Yang S, Graham J, Kahn JW, Schwartz EA, Gerritsen ME. 1999. Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. Am J Pathol 155: 887–895.
  • Yeaman C, Grindstaff KK, Nelson WJ. 1999. New perspectives on mechanisms involved in generating epithelial cell polarity. Physiol Rev 79: 73–98.
  • Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Yanoma S, Noguchi Y. 2001. Intratumoral concentrations of tissue inhibitor of matrix metalloproteinase 1 in patients with gastric carcinoma: a new biomarker for invasion and its impact on survival. Cancer 91: 1739–1744.
    Direct Link:
  • Yu TW, Bargmann CI. 2001. Dynamic regulation of axon guidance. Nat Neurosci 4: 1169–1176.
  • Yu WH, Yu S, Meng Q, Brew K, Woessner JF. 2000. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem 275: 31226–31232.
  • Yukawa N, Yoshikawa T, Akaike M, Sugimasa Y, Takemiya S, Yanoma S, Noguchi Y, Takanashi Y. 2001. Plasma concentration of tissue inhibitor of matrix metalloproteinase 1 in patients with colorectol carcinoma. Br J Surg 88: 1596–1601.
    Direct Link:
  • Zerial M, McBride H. 2001. Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2: 107–117.
  • Zhou X, Li J, Kucik DF. 2001. The microtubule cytoskeleton participates in control of beta2 integrin avidity. J Biol Chem 276: 44762–44769.
  • Zhu W-H, Guo X, Villaschi S, Nicosia RF. 2000. Regulation of vascular growth and regression by matrix metalloproteinases in the rat aorta model of angiogenesis. Lab Invest 80: 545–555.
  • Zimrin AB, Pepper MS, McMahon GA, Nguyen F, Montesano R, Maciag T. 1996. An antisense oligonucleotide to the notch ligand jagged enhances fibroblast growth factor-induced angiogenesis in vitro. J Biol Chem 271: 32499–32502.
View Full Article (HTML) Get PDF (2892K)